SILMA Silmaasema OYJ

Silmäasema Oyj: Silmäasema’s new strategy and updated financial targets – renewing the eyesight market and growing profitably

Silmäasema Oyj: Silmäasema’s new strategy and updated financial targets – renewing the eyesight market and growing profitably

Silmäasema Oyj

Inside Information

16 August 2019 7:45 a.m. EET



Silmäasema’s new strategy and updated financial targets

–renewing the eyesight market and growing profitably



Silmäasema’s Board of Directors has today confirmed the company’s strategy and financial targets for 2020–2022. The Board has also confirmed the company’s updated dividend policy.

During the strategy period, Silmäasema seeks to develop into customers’ preferred good eyesight partner that comprehensively responds to their changing needs and offers the most suitable solutions for good eyesight for people of different ages, in various environments and situations and for all eye healthcare issues.

In line with its strategy, the company’s growth and profitability will be based on becoming customers’ preferred choice and the leading expert in eye healthcare, renewing and growing the eyesight market, and improving performance and profitability.

Silmäasema’s financial targets for 2020-2022

  • Net sales growth outpacing the market
  • EBITDA more than 20% of net sales
  • Growth in earnings per share (EPS)
  •  Annually increasing dividend

The financial targets reflect the company’s view of opportunities to create value during the strategy period, which runs until the end of 2022. Silmäasema will not regard its financial targets as profit guidance for any financial year.

Silmäasema aims at strong growth in profitability and at outpacing the Finnish eyesight and eye healthcare market in terms of net sales growth, which would currently mean an annual increase in Silmäasema's net sales of over 4 percent.

In accordance with the updated dividend policy, Silmäasema seeks to increase annually the dividend to be distributed, considering the company’s financial situation, financial standing and investments required for strategy implementation.

A new focus on customers

Silmäasema’s new strategy is centred on people’s individual and changing eyesight needs. During the strategy period, the company seeks to develop into customers’ preferred partner that comprehensively responds to their changing eyesight needs and offers the most suitable solutions for good eyesight for people of different ages, in various environments and situations and for all eye healthcare issues.

Silmäasema is better positioned to respond to good eyesight needs than other operators in the field. It has the only offering in the market that combines optical retail with eye clinic services, in addition to having the capacity for active customer relationship management, personal service and the continuous development of interaction with customers. During the strategy period, key capabilities include the ability to rapidly identify, conceptualise and commercialise growth opportunities, and identify and utilise new opportunities created by technology and digitalisation.

Customers’ preferred choice

Silmäasema seeks to fully seize the opportunities created by Finland’s growing optical retail and eye healthcare market, as well as being the preferred choice for an increasing number of customers. This is supported by strengths that Silmäasema has developed systematically over the long term: highly competent employees, a unique range of services and a comprehensive service network.

Silmäasema seeks to strengthen its position in its customers’ lives by focusing on systematic and active customer relationship management and strengthening the related capabilities. During the strategy period, Silmäasema will markedly improve its ability to use data and analytics responsibly to improve the customer experience and further develop service paths, for example. In addition, Silmäasema will further strengthen its position as a trusted good eyesight brand.

Renewing and growing the eyesight market

Silmäasema seeks to outpace the Finnish optical retail and eye healthcare market in terms of net sales growth. Silmäasema seeks growth by increasing the sales of its existing products and services, making use of new growth opportunities and further developing the geographical focus of its business operations.

In terms of growth opportunities, Silmäasema is focusing on expanding its eye healthcare and other services, exploring new types of customer segments and sales channels and making effective use of digitalisation. The company is actively developing its geographical focus in response to the rapid urbanisation in Finland and the concentration of purchasing power in growth centres. On the other hand, digitalisation makes it possible to provide services independent of place. International growth opportunities will be evaluated towards the end of the strategy period.

Improving performance and productivity

In 2018, Silmäasema started a renewal of its operating model and information systems. This project supports the improvement of profitability and efficiency during the strategy period. Silmäasema seeks to improve its performance by further developing process efficiency in its network-like business operations and by renewing sales and chain management. In its eye clinic operations of a high medical quality, Silmäasema focuses on operational excellence and on renewing its cooperation model for ophthalmologists. The management of fixed operating costs lays the foundation for the continuous improvement of productivity.

Capital Markets Day

Silmäasema’s strategy and its implementation will be presented in more detail at the Capital Markets Day event for institutional investors in Helsinki on 18 September 2019, and at other investor meetings during the autumn. The presentations given at the Capital Markets Day event will be available on Silmäasema’s website at after the event.



SILMÄASEMA OYJ

Jussi Salminen

CEO

For further information, please contact:

CEO Jussi Salminen, tel. +358 40 834 5818

CFO Sari Nordblad, tel. 7

Mikko Merisaari, Head of Communications and Investor Relations, tel. +358 50 521 4055

Silmäasema is a Finnish company with a comprehensive range of products and services for optical retail and eye healthcare nationwide. Silmäasema runs Finland’s largest chain of private eye clinics offering eye surgeries and the country’s second largest optical retail chain. The Silmäasema chain has nearly 150 stores and 14 eye clinics in Finland and nine stores in Estonia. The Silmäasema chain employs more than 1,000 eyesight and eye healthcare professionals. The Silmäasema Group’s net sales were EUR 122.9 million and its adjusted EBITDA was EUR 11.8 million in 2018.

EN
16/08/2019

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Silmaasema OYJ

 PRESS RELEASE

Silmäasema Oyj: Coronaria Oy Has Gained Title to All the Shares in Si...

Silmäasema Oyj: Coronaria Oy Has Gained Title to All the Shares in Silmäasema Oyj and the Shares Have Been Delisted from Nasdaq Helsinki Coronaria Oy Has Gained Title to All the Shares in Silmäasema Oyj and the Shares Have Been Delisted from Nasdaq Helsinki Silmäasema Oyj Stock Exchange Release – Tender Offer 5 May 2020 at 4:00 p.m. EEST Coronaria Oy (“Coronaria”) has today placed security approved by the Arbitral Tribunal and thus gained title to all the shares in Silmäasema Oyj (“Silmäasema”) in accordance with Chapter 18, Section 6 of the Finnish Companies Act. After the security has...

 PRESS RELEASE

Silmäasema Oyj: Coronaria Oy on saanut omistusoikeuden Silmäasema Oy...

Silmäasema Oyj: Coronaria Oy on saanut omistusoikeuden Silmäasema Oyj:n kaikkiin osakkeisiin ja osakkeet ovat poistuneet Nasdaq Helsingin pörssilistalta Coronaria Oy on saanut omistusoikeuden Silmäasema Oyj:n kaikkiin osakkeisiin ja osakkeet ovat poistuneet Nasdaq Helsingin pörssilistalta Silmäasema Oyj                    Pörssitiedote – julkinen ostotarjous                                   5.5.2020 klo 16.00 Coronaria Oy (”Coronaria”) on tänään asettanut välimiesoikeuden hyväksymän vakuuden ja näin ollen saanut omistusoikeuden kaikkiin Silmäasema Oyj:n (”Silmäasema”) osakkeisiin osa...

 PRESS RELEASE

Silmäasema Oyj: Arbitral Tribunal Has Confirmed Coronaria Oy's Redemp...

Silmäasema Oyj: Arbitral Tribunal Has Confirmed Coronaria Oy's Redemption Right to Silmäasema Oyj's Shares and Trading in Silmäasema’s Shares Has Been Suspended Arbitral Tribunal Has Confirmed Coronaria Oy's Redemption Right to Silmäasema Oyj's Shares and Trading in Silmäasema’s Shares Has Been Suspended Silmäasema Oyj Stock Exchange Release – Tender Offer 28 April 2020 at 9:50 a.m. EEST The Arbitral Tribunal appointed by the Redemption Committee of the Finland Chamber of Commerce has on 27 April 2020 confirmed that Coronaria Oy (“Coronaria”) has the right to redeem the minority shares ...

 PRESS RELEASE

Silmäasema Oyj: Välimiesoikeus on vahvistanut Coronaria Oy:n lunastu...

Silmäasema Oyj: Välimiesoikeus on vahvistanut Coronaria Oy:n lunastusoikeuden Silmäasema Oyj:n osakkeisiin ja kaupankäynti Silmäaseman osakkeilla on keskeytetty Välimiesoikeus on vahvistanut Coronaria Oy:n lunastusoikeuden Silmäasema Oyj:n osakkeisiin ja kaupankäynti Silmäaseman osakkeilla on keskeytetty Silmäasema Oyj                    Pörssitiedote – julkinen ostotarjous                                   28.4.2020 klo 9.50 Keskuskauppakamarin lunastuslautakunnan nimittämä välimiesoikeus on 27.4.2020 vahvistanut, että Coronaria Oy:llä (”Coronaria”) on oikeus lunastaa Silmäasema Oyj:n...

 PRESS RELEASE

Silmäasema Oyj: Silmäasema Oyj hakee osakkeidensa poistamista Nasdaq...

Silmäasema Oyj: Silmäasema Oyj hakee osakkeidensa poistamista Nasdaq Helsingin pörssilistalta Silmäasema Oyj hakee osakkeidensa poistamista Nasdaq Helsingin pörssilistalta Silmäasema Oyj                    Pörssitiedote - sisäpiiritieto                         16.4.2020 klo 16.05  Silmäasema Oyj:n (”Silmäasema”) hallitus on päättänyt hakea julkisen kaupankäynnin lopettamista Silmäaseman osakkeilla sekä Silmäaseman osakkeiden poistamista Nasdaq Helsinki Oy:n (”Nasdaq Helsinki”) pörssilistalta. Coronaria Oy (”Coronaria”) omistaa yli yhdeksän kymmenesosaa (9/10) kaikista Silmäaseman osakk...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch